Replimune Group, Inc. (REPL)
4.71
-0.30
(-5.99%)
USD |
NASDAQ |
May 19, 16:00
4.72
+0.01
(+0.21%)
After-Hours: 16:22
Replimune Group EPS Diluted (TTM) : -3.582 for Dec. 31, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| REGENXBIO, Inc. | -5.59 |
| Catalyst Pharmaceuticals, Inc. | 1.740 |
| Spyre Therapeutics, Inc. | -2.358 |
| Bristol Myers Squibb Co. | 3.563 |
| ANI Pharmaceuticals, Inc. | 3.942 |